trolamine salicylate has been researched along with Latent Tuberculosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, S; Jeong, DH; Jo, KW; Kang, J; Kim, YG; Lee, CK; Shim, TS; Yoo, B | 1 |
| Cantarini, L; Caso, F; Costa, L; Punzi, L; Rigante, D; Rose, CD; Sfriso, P; Tognon, S; Wouters, CH | 1 |
| Contatore, M; Guastalla, A; Murdaca, G; Puppo, F; Spanò, F | 1 |
| Bourgarit, A; Lortholary, O; Mariette, X; Nicolas, N; Rivoisy, C; Roy, C; Salmon, D; Tubach, F | 1 |
| Bresnihan, B; Codd, MB; Dodd, J; Fearon, U; Fitzgerald, O; Gibbs, A; Keane, J; Martin, J; McDonnell, T; Veale, D; Walsh, C | 1 |
| Akcakaya, N; Arisoy, N; Camcioglu, Y; Cokugras, H; Kasapcopur, O; Kilic, O | 1 |
| Beutler, A; Cush, JJ; Doyle, MK; Hsia, EC; Hsu, B; Matteson, EL; Rahman, MU; Xu, S | 1 |
1 review(s) available for trolamine salicylate and Latent Tuberculosis
| Article | Year |
|---|---|
Potential use of TNF-α inhibitors in systemic sclerosis.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Antirheumatic Agents; Arthritis; Certolizumab Pegol; Drug Evaluation; Drug Therapy, Combination; Endothelium, Vascular; Etanercept; Forecasting; Humans; Hypertension, Pulmonary; Immunoglobulin Fab Fragments; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Latent Tuberculosis; Opportunistic Infections; Polyethylene Glycols; Pulmonary Fibrosis; Receptors, Tumor Necrosis Factor; Scleroderma, Systemic; Tumor Necrosis Factor-alpha | 2014 |
1 trial(s) available for trolamine salicylate and Latent Tuberculosis
| Article | Year |
|---|---|
Comprehensive tuberculosis screening program in patients with inflammatory arthritides treated with golimumab, a human anti-tumor necrosis factor antibody, in Phase III clinical trials.
Topics: Adult; Aged; Antibodies, Monoclonal; Antitubercular Agents; Arthritis; Chemical and Drug Induced Liver Injury; Female; Humans; Isoniazid; Latent Tuberculosis; Male; Middle Aged; Recurrence; Tumor Necrosis Factor-alpha; Young Adult | 2013 |
5 other study(ies) available for trolamine salicylate and Latent Tuberculosis
| Article | Year |
|---|---|
The usefulness of routine chest radiograph examinations in patients treated with TNF inhibitors for inflammatory arthritis in South Korea.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Cohort Studies; Etanercept; Female; Humans; Inflammation; Infliximab; Latent Tuberculosis; Male; Middle Aged; Radiography, Thoracic; Republic of Korea; Retrospective Studies; Tumor Necrosis Factor-alpha | 2018 |
Blau syndrome and latent tubercular infection: an unresolved partnership.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antitubercular Agents; Arthritis; Cranial Nerve Diseases; Female; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Latent Tuberculosis; Mutation; Nod2 Signaling Adaptor Protein; Risk Factors; Sarcoidosis; Synovitis; Time Factors; Treatment Outcome; Uveitis | 2014 |
Paradoxical anti-TNF-associated TB worsening: Frequency and factors associated with IRIS.
Topics: Adult; Aged; Arthritis; Biological Therapy; Case-Control Studies; Disease Progression; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Immunosuppressive Agents; Latent Tuberculosis; Male; Middle Aged; Registries; Retrospective Studies; Risk Factors; Skin Diseases, Vascular; Tuberculosis; Tumor Necrosis Factor-alpha | 2016 |
Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Humans; Interferon-gamma; Latent Tuberculosis; Mass Screening; Middle Aged; Tuberculin Test; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?
Topics: Adalimumab; Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis; Arthritis, Juvenile; Arthritis, Psoriatic; Child; Child, Preschool; Comorbidity; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Incidence; Infliximab; Latent Tuberculosis; Male; Radiography, Thoracic; Receptors, Tumor Necrosis Factor; Retrospective Studies; Rheumatic Diseases; Treatment Outcome; Tuberculin Test; Tumor Necrosis Factor-alpha; Turkey; Young Adult | 2012 |